Glycans in nanomedicine, impact and perspectives

被引:25
|
作者
Sampaolesi, Susanna [1 ]
Nicotra, Francesco [1 ]
Russo, Laura [1 ]
机构
[1] Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy
基金
欧盟地平线“2020”;
关键词
biomaterials; drug delivery; glycans; nanoparticles; regenerative medicine; DEXTRAN SULFATE NANOPARTICLES; ACID-CHITOSAN NANOPARTICLES; POLYELECTROLYTE COMPLEX NANOPARTICLES; COATED GOLD NANOPARTICLES; DRUG-DELIVERY; PECTIN NANOPARTICLES; POLYSIALIC ACID; GENE DELIVERY; IN-VIVO; ALGINATE/CHITOSAN NANOPARTICLES;
D O I
10.4155/fmc-2018-0368
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Glycans have been selected by nature for both structural and recognition' purposes. Taking inspiration from nature, nanomedicine exploits glycans not only as structural constituents of nanoparticles and nanostructured biomaterials but also as selective interactors of such glyco-nanotools. Surface glycosylation of nanoparticles finds application in targeting specific cells, whereas recent findings give evidence that the glycan content of cell microenvironment is able to induce the cell fate. This review will highlight the role of glycans in nanomedicine, schematizing the different uses and roles in drug-delivery systems and in biomaterials for regenerative medicine. [GRAPHICS] .
引用
收藏
页码:43 / +
页数:18
相关论文
共 50 条
  • [1] Glycans and diagnostics in nanomedicine
    Russo, Laura
    [J]. NANOMEDICINE, 2021, 16 (21) : 1839 - 1842
  • [2] Glycans in nanomedicine: where are we now?
    Russo, Laura
    [J]. NANOMEDICINE, 2020, 15 (24) : 2325 - 2328
  • [3] New perspectives in nanomedicine
    Thorley, Andrew J.
    Tetley, Teresa D.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2013, 140 (02) : 176 - 185
  • [4] Nanomedicine: pharmacological perspectives
    Bhattacharya, Santanu
    Alkharfy, Khalid M.
    Janardhanan, Rajiv
    Mukhopadhyay, Debabrata
    [J]. NANOTECHNOLOGY REVIEWS, 2012, 1 (03) : 235 - 253
  • [5] Nanomedicine-Challenge and Perspectives
    Riehemann, Kristina
    Schneider, Stefan W.
    Luger, Thomas A.
    Godin, Biana
    Ferrari, Mauro
    Fuchs, Harald
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (05) : 872 - 897
  • [6] GLYCANS AS BIOMARKERS: STATUS AND PERSPECTIVES
    Jankovic, Miroslava
    [J]. JOURNAL OF MEDICAL BIOCHEMISTRY, 2011, 30 (03) : 213 - 223
  • [7] Perspectives and opportunities for nanomedicine in the management of atherosclerosis
    Mark E. Lobatto
    Valentin Fuster
    Zahi A. Fayad
    Willem J. M. Mulder
    [J]. Nature Reviews Drug Discovery, 2011, 10 : 835 - 852
  • [8] Perspectives and opportunities for nanomedicine in the management of atherosclerosis
    Lobatto, Mark E.
    Fuster, Valentin
    Fayad, Zahi A.
    Mulder, Willem J. M.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (11) : 835 - 852
  • [9] Application Perspectives of Nanomedicine in Cancer Treatment
    Hou, Shanshan
    Hasnat, Muhammad
    Chen, Ziwei
    Liu, Yinong
    Faran Ashraf Baig, Mirza Muhammad
    Liu, Fuhe
    Chen, Zelong
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Perspectives and challenges of nanomedicine in gene silencing
    [J]. 1600, Advanstar Communications Inc. (38):